{
    "code": "02023145",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023145",
    "time": "2020-02-25 13:03:59",
    "許可證字號": "衛署藥輸字第023145號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/03\/20",
    "發證日期": "90\/03\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202314507",
    "中文品名": "睛晶點眼液",
    "英文品名": "MARINE EYE GOLD",
    "適應症": "暫時緩解因輕微眼部刺激所引起之不適或眼睛紅。",
    "劑型": "472點眼液劑",
    "包裝": "100公撮以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CHLORPHENIRAMINE MALEATE, NAPHAZOLINE HCL, DIPOTASSIUM GLYCYRRHIZINATE",
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "1511621100  德惠藥品有限公司",
    "申請商地址": "高雄市苓雅區武廟路107號12樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0517000  SAGA PHARMACEUTICAL CO., LTD.",
            "製造廠廠址": "481 KOKURA OAZA KIYAMA-MACHI MIYAKI-GUN SAGAKEN JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FIN0130000  PRECISE CHEMIPHARMA PVT. LTD.",
            "製造廠廠址": "C-384, T.T.C. INDUSTRIAL AREA, M.I.D.C., PAWNE VILLAGE, NAVI MUMBAI-400 703 INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FJP0919000  Nippon Bulk Yakuhin Co., Ltd. Delivery Center",
            "製造廠廠址": "2-3 Shingenkitamachi, Daito-sho, Osaka",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "包裝及釋出"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000810",
            "成分名稱": "CHLORPHENIRAMINE MALEATE",
            "含量描述": "",
            "含量": "0.3000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1212001910",
            "成分名稱": "NAPHAZOLINE HCL",
            "含量描述": "",
            "含量": "0.0300000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200004680",
            "成分名稱": "DIPOTASSIUM GLYCYRRHIZINATE",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛署藥輸字第023145號-睛晶點眼液-仿單-107-01-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023145&Seq=002&Type=9"
        },
        {
            "title": "衛署藥輸字第023145號-睛晶點眼液-外盒-107-09-12-107-09-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023145&Seq=004&Type=8"
        },
        {
            "title": "衛署藥輸字第023145號-睛晶點眼液-外盒-107-01-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023145&Seq=001&Type=8"
        }
    ]
}